Published in Br J Gen Pract on November 01, 2005
Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA (2013) 3.55
Quality-improvement strategies for the management of hypertension in chronic kidney disease in primary care: a systematic review. Br J Gen Pract (2010) 1.63
Behavior change interventions and policies influencing primary healthcare professionals' practice-an overview of reviews. Implement Sci (2017) 1.41
Self-monitoring and other non-pharmacological interventions to improve the management of hypertension in primary care: a systematic review. Br J Gen Pract (2010) 1.38
The influence of health systems on hypertension awareness, treatment, and control: a systematic literature review. PLoS Med (2013) 1.20
Self-Monitoring of Blood Pressure in Hypertension: A UK Primary Care Survey. Int J Hypertens (2011) 1.11
Factors associated with clinical inertia: an integrative review. Adv Med Educ Pract (2014) 1.04
Design and rationale for Home Blood Pressure Telemonitoring and Case Management to Control Hypertension (HyperLink): a cluster randomized trial. Contemp Clin Trials (2012) 0.99
A quality improvement plan for hypertension control: the INCOTECA Project (INterventions for COntrol of hyperTEnsion in CAtalonia). BMC Public Health (2009) 0.94
Racial disparities in kidney disease outcomes. Semin Nephrol (2013) 0.93
Organisational factors in relation to control of blood pressure: an observational study. Br J Gen Pract (2005) 0.92
Racial disparities in blood pressure control and treatment differences in a Medicaid population, North Carolina, 2005-2006. Prev Chronic Dis (2011) 0.91
Patient trust in physicians and adoption of lifestyle behaviors to control high blood pressure. Patient Educ Couns (2012) 0.90
Hypertension education intervention with ugandan nurses working in hospital outpatient clinic: a pilot study. Nurs Res Pract (2014) 0.85
A successful chronic care program in Al Ain-United Arab Emirates. BMC Health Serv Res (2010) 0.83
Patient registries for substance use disorders. Subst Abuse Rehabil (2014) 0.80
Trial and error. Br J Gen Pract (2006) 0.75
Intervention for control of hypertension in Catalonia, Spain (INCOTECA Project): results of a multicentric, non-randomised, quasi-experimental controlled intervention study. BMJ Open (2012) 0.75
CoCo trial: Color-coded blood pressure Control, a randomized controlled study. Patient Prefer Adherence (2014) 0.75
Review: care assisted by nurses or pharmacists provides better blood pressure control. ACP J Club (2006) 0.75
Collaborative hypertension case management by registered nurses and clinical pharmacy specialists within the Patient Aligned Care Teams (PACT) model. J Gen Intern Med (2014) 0.75
Review: Care assisted by nurses or pharmacists provides better blood pressure control. Evid Based Med (2006) 0.75
Recording blood pressure readings in elderly patients' charts: what patient and physician characteristics make it more likely? Can Fam Physician (2008) 0.75
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA (2003) 97.28
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ (1998) 32.73
Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet (2003) 12.67
2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens (2003) 11.32
Clinical inertia. Ann Intern Med (2001) 11.14
Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens (2004) 8.32
Randomised clinical trial of strategies for improving medication compliance in primary hypertension. Lancet (1975) 7.22
Inadequate management of blood pressure in a hypertensive population. N Engl J Med (1998) 7.16
Hypertension--a community problem. Am J Med (1972) 7.12
Interventions used in disease management programmes for patients with chronic illness-which ones work? Meta-analysis of published reports. BMJ (2002) 6.98
Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med (2001) 6.00
Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med (2002) 5.80
Does free care improve adults' health? Results from a randomized controlled trial. N Engl J Med (1983) 5.10
Improvement of medication compliance in uncontrolled hypertension. Lancet (1976) 4.84
Predisposing factors for severe, uncontrolled hypertension in an inner-city minority population. N Engl J Med (1992) 4.79
Variance imputation for overviews of clinical trials with continuous response. J Clin Epidemiol (1992) 4.72
Chronic illness management: what is the role of primary care?. Ann Intern Med (2003) 3.60
Blood pressure control by home monitoring: meta-analysis of randomised trials. BMJ (2004) 3.46
Antihypertensive treatment based on blood pressure measurement at home or in the physician's office: a randomized controlled trial. JAMA (2004) 3.33
Five-year blood pressure control and mortality following health education for hypertensive patients. Am J Public Health (1983) 3.33
Local confidential inquiry into avoidable factors in deaths from stroke and hypertensive disease. BMJ (1993) 3.25
A telecommunications system for monitoring and counseling patients with hypertension. Impact on medication adherence and blood pressure control. Am J Hypertens (1996) 3.19
Does a mailed continuing education program improve physician performance? Results of a randomized trial in antihypertensive care. JAMA (1986) 3.04
Using nurses for preventive activities with computer assisted follow up: a randomised controlled trial. BMJ (1989) 2.95
How can we improve adherence to blood pressure-lowering medication in ambulatory care? Systematic review of randomized controlled trials. Arch Intern Med (2004) 2.89
Blood pressure control in treated hypertensive patients: clinical performance of general practitioners. Br J Gen Pract (2001) 2.68
A computer-based monitoring system for follow-up of elevated blood pressure. Med Care (1983) 2.65
Health education for hypertensive patients. JAMA (1979) 2.62
Evaluation of a nurse-run hypertension clinic in general practice. Practitioner (1988) 2.49
Implementing clinical guidelines in the treatment of hypertension in general practice. Evaluation of patient outcome related to implementation of a computer-based clinical decision support system. Scand J Prim Health Care (1999) 2.39
Home monitoring service improves mean arterial pressure in patients with essential hypertension. A randomized, controlled trial. Ann Intern Med (2001) 2.31
Randomised controlled trial of computer assisted management of hypertension in primary care. Br Med J (Clin Res Ed) (1986) 2.24
How free care reduced hypertension in the health insurance experiment. JAMA (1985) 2.16
Randomised controlled trial of computer-held medical records in hypertensive patients. Br Med J (1976) 2.15
Case-control study of stroke and the quality of hypertension control in north west England. BMJ (1997) 2.10
Control of hypertension--an important national priority. N Engl J Med (2001) 1.81
Linking community-based blood pressure measurement to clinical care: a randomized controlled trial of outreach and tracking by community health workers. Am J Public Health (1999) 1.81
Comparing standard care with a physician and pharmacist team approach for uncontrolled hypertension. J Gen Intern Med (1998) 1.81
Clinical and economic outcomes in the hypertension and COPD arms of a multicenter outcomes study. J Am Pharm Assoc (Wash) (1998) 1.68
Pragmatic randomized trial of home visits by a nurse to elderly people with hypertension in Mexico. Int J Epidemiol (2001) 1.68
Effect of pharmacist intervention and initiation of home blood pressure monitoring in patients with uncontrolled hypertension. Pharmacotherapy (2000) 1.67
A multimethod quality improvement intervention to improve preventive cardiovascular care: a cluster randomized trial. Ann Intern Med (2004) 1.61
Detection, adherence and control of hypertension for the prevention of stroke: a systematic review. Health Technol Assess (1998) 1.56
Improving hypertension control: impact of computer feedback and physician education. Med Care (1981) 1.55
Work-site treatment of hypertension by specially trained nurses. A controlled trial. Lancet (1979) 1.53
Hypertension control: how well are we doing? Arch Intern Med (2003) 1.53
Effects of home telemonitoring and community-based monitoring on blood pressure control in urban African Americans: a pilot study. Heart Lung (2001) 1.52
Nurse management for hypertension. A systems approach. Am J Hypertens (2004) 1.52
Self-recording of blood pressure in the management of hypertension. Can Med Assoc J (1978) 1.46
A randomized controlled trial of an information booklet for hypertensive patients in general practice. J R Coll Gen Pract (1987) 1.46
The effects of self-monitoring by patients on the control of hypertension. Am J Med Sci (1975) 1.29
Evaluation of family health education to build social support for long-term control of high blood pressure. Health Educ Q (1985) 1.28
A randomized study comparing a patient-directed hypertension management strategy with usual office-based care. Am J Hypertens (1997) 1.27
Systolic and diastolic blood pressure control in antihypertensive drug trials. J Hypertens (2002) 1.25
Comprehensive pharmaceutical care in the chain setting. J Am Pharm Assoc (Wash) (1996) 1.22
Home blood pressure monitoring. Effect on use of medical services and medical care costs. Med Care (1992) 1.21
Initial care of hypertensive patients. Influence of different types of clinical records. Br Heart J (1977) 1.18
Management of hypertension. Effect of improving patient compliance for follow-up care. JAMA (1975) 1.13
Educational outreach in diabetes to encourage practice nurses to use primary care hypertension and hyperlipidaemia guidelines (EDEN): a randomized controlled trial. Diabet Med (2004) 1.08
Evaluation of a clinical pharmacist in caring for hypertensive and diabetic patients. Am J Hosp Pharm (1979) 1.08
JNC 7--it's more than high blood pressure. JAMA (2003) 1.07
The impact of a patient education programme in the control of hypertension. J Hum Hypertens (1991) 1.03
Blood pressure control and the implementation of guidelines in clinical practice: can we fill the gap? J Hypertens (2002) 1.02
Evaluation of the IMPACT blood pressure program. J Occup Med (1994) 1.01
The effects of family involvement and practitioner home visits on the control of hypertension. Am J Public Health (1982) 1.00
From screening to seeking care: removing obstacles in hypertension control. Prev Med (1979) 0.99
Antihypertensive drug treatment: a comparison of usual care with self blood pressure measurement. J Hum Hypertens (1999) 0.98
Treatment of hypertension by computer and physician-a prospective controlled study. J Chronic Dis (1977) 0.93
Influence of self-measurement of blood pressure on the responder rate in hypertensive patients treated with losartan: results of the SVATCH Study. Standard vs Automatic Treatment Control of COSAAR in Hypertension. J Hum Hypertens (2000) 0.93
Improving compliance with therapeutic regimens in hypertensive patients in a community health center. Circulation (1979) 0.93
Role of organizational factors in poor blood pressure control in patients with type 2 diabetes: the QuED Study Group--quality of care and outcomes in type 2 diabetes. Arch Intern Med (2003) 0.93
Evaluation of a structured treatment and teaching programme on hypertension in general practice. Clin Exp Hypertens (1993) 0.92
Improving hypertension control in a private medical practice. Arch Intern Med (1982) 0.91
A controlled trial of health education in the physician's office. Prev Med (1984) 0.91
Home blood pressure monitoring for mild hypertensives. Public Health Rep (1991) 0.90
Effectiveness of patient education and psychosocial counseling in promoting compliance and control among hypertensive patients. J Fam Pract (1980) 0.89
Physicians' management of hypertension: a randomized controlled CME trial. Res Med Educ (1987) 0.87
Screening, treatment and adherence to treatment for hypertension. Scand J Prim Health Care (1983) 0.87
Cost-effectiveness of educational interventions to improve patient outcomes in blood pressure control. Prev Med (1985) 0.86
Evaluation of two educative models in a primary care hypertension programme. J Hum Hypertens (1990) 0.85
Therapeutic control of blood pressure in the Hypertension Detection and Follow-up Program. Hypertension Detection and Follow-up Program Cooperative Group. Prev Med (1979) 0.84
Improving blood pressure control in diabetes: limitations of a clinical reminder in influencing physician behavior. J Contin Educ Health Prof (2002) 0.83
The effect of instruction on control of blood pressure in individuals with essential hypertension. J Adv Nurs (1981) 0.81
Use of a standardized personal medical record by patients with hypertension: a randomized controlled prospective trial. MD Comput (1995) 0.80
A randomized trial to improve follow-up care in severe uncontrolled hypertensives at an inner-city walk-in clinic. J Health Care Poor Underserved (1996) 0.80
An appointment reminder system's effect on reducing the number of hypertension patients who drop out from care. Am J Prev Med (1988) 0.78
A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science (2007) 37.88
Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet (2008) 25.83
Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet (2010) 23.08
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89
'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol (2003) 16.71
Priority actions for the non-communicable disease crisis. Lancet (2011) 15.18
European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J (2003) 8.51
Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am J Med (2004) 8.07
Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet (2010) 7.94
Common variants in the GDF5-UQCC region are associated with variation in human height. Nat Genet (2008) 7.31
Those confounded vitamins: what can we learn from the differences between observational versus randomised trial evidence? Lancet (2004) 6.37
European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil (2007) 6.10
Where is the evidence that animal research benefits humans? BMJ (2004) 5.99
Genome-wide association scan meta-analysis identifies three Loci influencing adiposity and fat distribution. PLoS Genet (2009) 5.81
Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev (2013) 5.57
Reduced dietary salt for the prevention of cardiovascular disease: a meta-analysis of randomized controlled trials (Cochrane review). Am J Hypertens (2011) 5.54
C-reactive protein and its role in metabolic syndrome: mendelian randomisation study. Lancet (2005) 5.51
Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev (2011) 5.30
Mendelian randomization: prospects, potentials, and limitations. Int J Epidemiol (2004) 5.07
Complex interventions to improve physical function and maintain independent living in elderly people: a systematic review and meta-analysis. Lancet (2008) 4.97
Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study. BMJ (2003) 4.74
Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev (2011) 4.72
The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection. Lancet Infect Dis (2007) 4.34
Improving the prevention and management of chronic disease in low-income and middle-income countries: a priority for primary health care. Lancet (2008) 4.32
Chronic diseases and injuries in India. Lancet (2011) 4.27
Raising the priority of preventing chronic diseases: a political process. Lancet (2010) 4.16
Genome-wide association study identifies five loci associated with lung function. Nat Genet (2009) 4.10
Interventions used to improve control of blood pressure in patients with hypertension. Cochrane Database Syst Rev (2010) 4.01
Physical activity attenuates the influence of FTO variants on obesity risk: a meta-analysis of 218,166 adults and 19,268 children. PLoS Med (2011) 3.94
Prevention of chronic diseases: a call to action. Lancet (2007) 3.87
Systematic review of long term effects of advice to reduce dietary salt in adults. BMJ (2002) 3.87
Common variation in the FTO gene alters diabetes-related metabolic traits to the extent expected given its effect on BMI. Diabetes (2008) 3.76
Genetic loci influencing kidney function and chronic kidney disease. Nat Genet (2010) 3.75
Clustered environments and randomized genes: a fundamental distinction between conventional and genetic epidemiology. PLoS Med (2007) 3.71
NHS waiting lists and evidence of national or local failure: analysis of health service data. BMJ (2003) 3.60
Variations in the G6PC2/ABCB11 genomic region are associated with fasting glucose levels. J Clin Invest (2008) 3.51
(Mis)use of factor analysis in the study of insulin resistance syndrome. Am J Epidemiol (2004) 3.43
European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Eur J Cardiovasc Prev Rehabil (2003) 3.43
Lessons from the withdrawal of rofecoxib. BMJ (2004) 3.33
Secular trends in mortality by stroke subtype in the 20th century: a retrospective analysis. Lancet (2002) 3.29
Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet (2012) 3.21
Chronic diseases and calls to action. Int J Epidemiol (2008) 3.11
WHO study on Prevention of REcurrences of Myocardial Infarction and StrokE (WHO-PREMISE). Bull World Health Organ (2005) 3.09
Non-communicable diseases in low and middle-income countries: a priority or a distraction? Int J Epidemiol (2005) 3.06
Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function. Nat Genet (2011) 3.03
Genetic epidemiology and public health: hope, hype, and future prospects. Lancet (2005) 3.00
Admissions for myocardial infarction and World Cup football: database survey. BMJ (2002) 2.99
Evaluating the impact of population and high-risk strategies for the primary prevention of cardiovascular disease. Eur Heart J (2004) 2.91
How can we improve adherence to blood pressure-lowering medication in ambulatory care? Systematic review of randomized controlled trials. Arch Intern Med (2004) 2.89
Data dredging, bias, or confounding. BMJ (2002) 2.87
Comparison of the associations of body mass index and measures of central adiposity and fat mass with coronary heart disease, diabetes, and all-cause mortality: a study using data from 4 UK cohorts. Am J Clin Nutr (2010) 2.82
Manufacturing epidemics: the role of global producers in increased consumption of unhealthy commodities including processed foods, alcohol, and tobacco. PLoS Med (2012) 2.71
European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil (2007) 2.70
Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis. Cancer Causes Control (2008) 2.68
Association between falls in elderly women and chronic diseases and drug use: cross sectional study. BMJ (2003) 2.63
What can mendelian randomisation tell us about modifiable behavioural and environmental exposures? BMJ (2005) 2.50
A systematic review of the association between circulating concentrations of C reactive protein and cancer. J Epidemiol Community Health (2007) 2.50
Gamma-glutamyltransferase is associated with incident vascular events independently of alcohol intake: analysis of the British Women's Heart and Health Study and Meta-Analysis. Arterioscler Thromb Vasc Biol (2007) 2.45
A common haplotype of the glucokinase gene alters fasting glucose and birth weight: association in six studies and population-genetics analyses. Am J Hum Genet (2006) 2.44
Cost-effectiveness of community-based strategies for blood pressure control in a low-income developing country: findings from a cluster-randomized, factorial-controlled trial. Circulation (2011) 2.44
The association between orthostatic hypotension and medication use in the British Women's Heart and Health Study. Age Ageing (2009) 2.43
Association of C-reactive protein with blood pressure and hypertension: life course confounding and mendelian randomization tests of causality. Arterioscler Thromb Vasc Biol (2005) 2.42
Reduced dietary salt for the prevention of cardiovascular disease. Cochrane Database Syst Rev (2011) 2.38
Folate supplementation and cardiovascular disease. Lancet (2005) 2.36
Hypertension among older adults in low- and middle-income countries: prevalence, awareness and control. Int J Epidemiol (2014) 2.33
Does psychological distress predict the risk of ischemic stroke and transient ischemic attack? The Caerphilly Study. Stroke (2002) 2.30
Fixed-dose combination therapy for the prevention of cardiovascular disease. Cochrane Database Syst Rev (2014) 2.24
Smoking and ill health: does lay epidemiology explain the failure of smoking cessation programs among deprived populations? Am J Public Health (2003) 2.23
Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women's Heart and Health Study and meta-analysis. Diabetes Care (2009) 2.23
Body mass index and ischemic and hemorrhagic stroke: a prospective study in Korean men. Stroke (2004) 2.22
Sociodemographic patterning of non-communicable disease risk factors in rural India: a cross sectional study. BMJ (2010) 2.21
Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways. Nat Genet (2012) 2.12
Balancing benefits and harms: the example of non-steroidal anti-inflammatory drugs. BMJ (2004) 2.12
Reduced dietary salt for the prevention of cardiovascular disease. Cochrane Database Syst Rev (2014) 2.10
Effect of five genetic variants associated with lung function on the risk of chronic obstructive lung disease, and their joint effects on lung function. Am J Respir Crit Care Med (2011) 2.07
Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip. Am J Hum Genet (2009) 2.04
Fasting blood glucose and the risk of stroke and myocardial infarction. Circulation (2009) 1.92
Is stroke the most common cause of disability? J Stroke Cerebrovasc Dis (2007) 1.92
Statin therapy for primary prevention of cardiovascular disease. JAMA (2013) 1.87
Association between genetic variants on chromosome 15q25 locus and objective measures of tobacco exposure. J Natl Cancer Inst (2012) 1.83
Palm oil taxes and cardiovascular disease mortality in India: economic-epidemiologic model. BMJ (2013) 1.81
Agreement between measured and self-reported weight in older women. Results from the British Women's Heart and Health Study. Age Ageing (2002) 1.78
Plasma adiponectin levels are associated with insulin resistance, but do not predict future risk of coronary heart disease in women. J Clin Endocrinol Metab (2005) 1.74
Association of insulin resistance with depression: cross sectional findings from the British Women's Heart and Health Study. BMJ (2003) 1.72
A genome-wide association search for type 2 diabetes genes in African Americans. PLoS One (2012) 1.72
Systematic review of the association between circulating interleukin-6 (IL-6) and cancer. Eur J Cancer (2008) 1.67
Over-the-counter (OTC) medications for acute cough in children and adults in community settings. Cochrane Database Syst Rev (2014) 1.65
Sedentary behaviors and the risk of incident hypertension: the SUN Cohort. Am J Hypertens (2007) 1.61
Genetic variation at the SLC23A1 locus is associated with circulating concentrations of L-ascorbic acid (vitamin C): evidence from 5 independent studies with >15,000 participants. Am J Clin Nutr (2010) 1.61
Genetic variation at CHRNA5-CHRNA3-CHRNB4 interacts with smoking status to influence body mass index. Int J Epidemiol (2011) 1.61
Over-the-counter (OTC) medications for acute cough in children and adults in ambulatory settings. Cochrane Database Syst Rev (2012) 1.57
The association of oestrogen receptor alpha-haplotypes with cardiovascular risk factors in the British Women's Heart and Health Study. Eur Heart J (2006) 1.57